megestrol acetate has been researched along with Carcinoma in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (26.32) | 18.7374 |
| 1990's | 12 (63.16) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casazza, AM; Horwitz, SB; Trail, PA; Wang, L; Yang, CP | 1 |
| DiLeonardo, M; Gibbons, G; Resnik, KS | 1 |
| Denschlag, D; Gilbert, L; Kerim-Dikeni, A; Patel, S; Souhami, L; Tan, L | 1 |
| Burger, CW; Greggi, S; Kenemans, P; van der Vange, N; Vermorken, JB | 1 |
| Ahlgren, JD; Alt, D; Ellison, NM; Gottlieb, RJ; Laluna, F; Lokich, JJ; Sinclair, PR; Ueno, W; Wampler, GL; Yeung, KY | 1 |
| Harrison-Woolrych, M; Robinson, R | 1 |
| Espie, M | 1 |
| Demers, L; Grossberg, H; Leitzel, K; Lipton, A; Teramoto, Y; Volas, GH | 1 |
| Fietkau, R; Hinke, A; Kettner, H; Riepl, M; Sauer, R | 1 |
| Cavanagh, D; Fiorica, JV; Hoffman, MS; Nicosia, SV; Pinelli, DM; Roberts, WS | 1 |
| Buzdar, AU; Jones, SE; Plourde, P; Vogel, CL; Webster, A; Wolter, J | 1 |
| Chen, J; Cheng, AL; Guan, JY; Hsieh, CY; Lai, MK; Lu, SH; Pu, YS | 1 |
| Daniel, F; Rao, DG; Tyrrell, CJ | 1 |
| Daniel, F; MacLeod, PM; Tyrrell, CJ | 1 |
| Hickey, D; Soloway, MS; Todd, B | 1 |
| Ballon, SC; Brandt, AE; Christman, JE; Ehsan, MN; Evans, TL; Scudder, SA; Sikic, BI; Soriero, OM; Suey, L | 1 |
| Badger, G; Belinson, JL; McClure, M | 1 |
| Geller, J | 1 |
| Benghiat, A; Cassidy, SA; Davidson, HE; Mancero, FS; Pickard, JG; Tyrrell, CJ | 1 |
7 trial(s) available for megestrol acetate and Carcinoma
| Article | Year |
|---|---|
Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program.
Topics: Adenocarcinoma; Aminoglutethimide; Carcinoma; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Megestrol; Megestrol Acetate; Ovarian Neoplasms; Palliative Care; Tamoxifen | 1993 |
Serial serum c-erbB-2 levels in patients with breast carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Fadrozole; Female; Humans; Megestrol; Megestrol Acetate; Placebos; Prognosis; Receptor, ErbB-2; Remission Induction; Treatment Outcome | 1996 |
[Supportive treatment with megestrol acetate during radio(chemo)therapy in patients with tumors in the head-neck area. A randomized study].
Topics: Anthropometry; Appetite; Carcinoma; Combined Modality Therapy; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Megestrol Acetate; Middle Aged; Quality of Life; Stimulation, Chemical; Time Factors; Weight Loss | 1996 |
Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma: a phase II study.
Topics: Adult; Aged; Carboplatin; Carcinoma; Disease Progression; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tamoxifen | 1996 |
A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Pregnanes; Triazoles | 1997 |
Megestrol acetate in relapsed carcinoma of prostate.
Topics: Carcinoma; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Orchiectomy; Prostatic Neoplasms | 1990 |
Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinoma.
Topics: Adult; Carcinoma; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Random Allocation; Tamoxifen | 1987 |
12 other study(ies) available for megestrol acetate and Carcinoma
| Article | Year |
|---|---|
Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Colonic Neoplasms; Dactinomycin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Humans; Mammary Neoplasms, Experimental; Megestrol; Megestrol Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Phenotype; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
Clinically occult cutaneous metastases.
Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Capecitabine; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Lobular; Carcinoma, Signet Ring Cell; Deoxycytidine; Estradiol; Facial Neoplasms; Female; Fluorouracil; Fulvestrant; Humans; Incidental Findings; Letrozole; Mastectomy, Radical; Megestrol Acetate; Melanoma; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Nitriles; Selective Estrogen Receptor Modulators; Skin Neoplasms; Tamoxifen; Triazoles; Wound Healing | 2006 |
Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome.
Topics: Adnexa Uteri; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Canada; Carcinoma; Chemotherapy, Adjuvant; Cystadenoma, Serous; Endometrial Neoplasms; Fallopian Tubes; Female; Humans; Hysterectomy; Lymph Node Excision; Megestrol Acetate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Ovariectomy; Prognosis; Radiotherapy, Adjuvant; Registries | 2007 |
Experience with hormonal therapy in advanced epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Carcinoma; Estrogen Antagonists; Female; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteolytic Agents; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Progesterone Congeners; Remission Induction; Survival Rate; Tamoxifen; Triptorelin Pamoate | 1995 |
Fibroid growth in response to high-dose progestogen.
Topics: Breast Neoplasms; Carcinoma; Dose-Response Relationship, Drug; Female; Humans; Leiomyoma; Megestrol; Megestrol Acetate; Middle Aged; Progestins; Tamoxifen; Ultrasonography; Uterine Neoplasms | 1995 |
Megestrol acetate in advanced breast carcinoma.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cross-Over Studies; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome | 1994 |
Megestrol acetate antagonizes cisplatin cytotoxicity.
Topics: Antineoplastic Agents; Appetite Stimulants; Carcinoma; Cisplatin; Glutathione; Glutathione Transferase; Humans; Megestrol Acetate; Metallothionein; Tumor Cells, Cultured | 1998 |
A pilot study of stanozolol for advanced breast carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Humans; Lymphatic Metastasis; Megestrol; Megestrol Acetate; Middle Aged; Pilot Projects; Remission Induction; Stanozolol; Tamoxifen | 1991 |
Pre-treatment testosterone levels: significance in androgen deprivation therapy.
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Carcinoma; Drug Evaluation; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Tumor Stem Cell Assay | 1986 |
Megestrol acetate and minidose estrogen in prostatic carcinoma.
Topics: Carcinoma; Drug Therapy, Combination; Estradiol Congeners; Humans; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms | 1988 |
Megestrol acetate in the treatment of advanced post-menopausal breast cancer.
Topics: Aged; Body Weight; Breast Neoplasms; Carcinoma; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Tamoxifen; Time Factors | 1986 |